HBV Vaccines
"Immunogenicity of a Recombinant Hepatitis B Vaccine in Adults."
Published in Vaccine Weekly, December 23rd, 1996
According to the authors' abstract of an article published in Archives of Internal Medicine, "Objectives: To evaluate the immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in health care staff under routine use and unselected conditions and to investigate factors that influence the response to vaccination. Methods: This prospective postmarketing surveillance study was performed in unselected health care staff and their relatives (age range, 12-60 years) at 58 hospitals. Overall, 880 subjects were administered a 20-(mu)g dose of a vaccine at 0, 1, and 6 months according to the prescribing information and under routine hospital practice, and they were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1996-12-23)
More Articles from Vaccine Weekly
- Biological Warfare
Vaccine Defends Against Biological Warfare Agent - Plague
V Antigen Improves Vaccine - Cancer Vaccines
Collaboration Initiated to Develop Brain Cancer Treatment - DNA Vaccines
Long-Term Antiviral Immunity Possible with Gene-Gun Inoculation - Genetics
Molecular Mechanisms Identified that Allow HIV to Enter Human Cells - HBV Vaccines
MF59 Adjuvant May Improve Hepatitis B Vaccine - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
